Poster SESSIONS
48
Poster, 23 June 2014
P-03-007
Cognitive styles in bipolar disorder and uni-
polar depression
Venkat Bhat, Montreal, Canada
J. Cohen, A. Iskric, G. Kraus, N. Low
P-03-008
Efficacy and safety of treatment with lur-
asidone adjunctive with lithium or valpro-
ate in bipolar I depression: Results of two
6-week studies
Joseph Calabrese, Cleveland, OH, USA
T. Suppes, K. Sarma, R. Silva, J. Cucchiaro,
A. Pikalov, A. Loebel
P-03-009
Insulin resistance: An occult, modifiable risk
factor for refractory bipolar disorder?
Cynthia Calkin, Halifax, Canada
M. Ruzickova, C. Slaney, J. Garnham, R. Uher,
C. O´Donovan, M. Alda
P-03-010
Differential changes in metabolic profile of
bipolar patients following switching to ar-
ipiprazole
Jae Seung Chang, Seongnam, Republic of Korea
T. H. Ha, H. Y. Jung, K. Ha
P-03-011
Mental disorders in offspring of parents with
bipolar disorders in Korea
Young-Sung Cho, Cheonan, Republic of Korea
S.-H. Shim, Y.-J. Kwon, H.-Y. Lee
P-03-012
Effects of cytokines on brain serotonin trans-
porter in bipolar I disorder
Yuan-Hwa Chou, Taipei, Taiwan
P-03-013
Clinical assessment of lurasidone benefit
and risk in the treatment of bipolar I depres-
sion using number needed to treat, number
needed to harm, and likelihood to be helped
or harmed
Leslie Citrome, Suffern, USA
T. Ketter, J. Cucchiaro, A. Loebel
P-03-014
Categorical improvements in severity of ma-
nia and schizophrenia symptoms: Pooled
analyses of cariprazine phase II/III trials
Suresh Durgam, Jersey City, USA
I. Laszlovszky, K. Nagy, K. Lu, S. Volk, R. Litman
P-03-015
Naturalistic study of efficacy of acute treat-
ment with lithium and valproate in the treat-
ment of manic inpatients
Evaristo Nieto, Manresa, Spain
L. Plans, M. Gallardo, A. Gomez
P-03-016
Naturalistic study of efficacy of acute treat-
ment with paliperidone palmitate as add-on
therapy in the treatment of manic inpatients
Evaristo Nieto, Manresa, Spain
J. Carreras, M. Rius, M. Puig
P-03-017
Inflammation associated with elevation of
triglyceride in subsequent remission of bi-
polar mania
Shangying Tsai, Taipei, Taiwan
K.-H. Chung, S.-H. Huang, P.-H. Chen
P-04
POSTER SESSION
17:15–18:45
Hall B
Depression A
P-04-001
COMT gene polymorphism, plasma MHPG,
and response to duloxetine in Japanese MDD
patients
Kiyokazu Atake, Kitkyushu, Japan
R. Yoshimura, A. Katsuki, H. Hori, A. Sugita,
J. Nakamura
P-04-002
A novel anesthetical method of ECT using
remifentanil, rocuronium and sugammadex,
in a patient with depression and Brugada
syndrome
Yasutaka Fujita, Hiroshima, Japan
Y. Demoto, K. Nakatsu, T. Miyazaki, K. Tahara,
A. Hiraoka, T. Sato, G. Sato
P-04-003
Early treatment improvement in predicting
later remission in Asian patients with major
depressive disorder treated with mirtazapine
Kei Funaki, Tokyo, Japan
S. Nakajima, T. Suzuki, R. Kitahata, M. Naga-
oka, M. Mimura, H. Uchida
P-04-004
Effect of mirtazapine for benzodiazepines
use compared with selective serotonin reup-
take inhibitors in patients with major de-
pressive disorder: A multicenter, open-label,
randomized, controlled trial
Tasuku Hashimoto, Chiba, Japan
A. Shiina, T. Hasegawa, H. Kimura, T. Niitsu,
M. Tachibana, K. Muneoka, S. Matsuki, M. Na-
kazato, T. Shiraishi, M. Iyo
P-04-005
Differentiated uses of antidepressant agents
Yoshiro Hayashi, Koshi, Japan
